Polio vaccines poliomyelitis

Polio is the only disease, at present, for which both hve and killed vaccines compete. Since the introduction of the killed vims (Salk) in 1956 and the live attenuated virus (Sabin) in 1962 there has been a remaikable decline in the incidence of poliomyelitis (Fig. 16.1). The inactivated polio vaccine (TPV) contains formalin-killed poliovirus of all three serotypes. On injection, the vaccine stimulates the production of antibodies of the IgM and IgG class which neutrahze the vims in the second stage of infection. A course of three injections at monthly intervals produces long-lasting immunity to all three poliovirus types. 

Poliomyelitis (polio) IPV (Inactivated poliovirus vaccine) OPV (Oral polio vaccine) Cell based... 

There are two types of pohomyelitis vaccines available. One is prepared from pohoviruses that as a rule have been inactivated by formaldehyde. Inactivated poliomyelitis vaccine (IPV) is given parenterally. The second group of polio vaccines comprises attenuated strains of live polioviruses (oral poliomyelitis vaccine, OPV), which are given orally these live vaccines are the most widely used. 

On the other hand, we must not forget that the ultimate goal of an immunization program is control of disease or even its regional elimination or worldwide eradication. A successful immunization program can lead to the eradication of disease and opens up the possibility of ultimately abandoning immunization (and with it the occurrence of adverse effects) completely. Smallpox eradication made it possible to stop smallpox immunization and poliomyelitis eradication, which is expected to be achieved within a few years, will mean the end of polio vaccine. 

An analogous example in the civilian context could be made in the case of polio immunizations, where a 1 in 2.4 million chance exists that an oral polio virus vaccine will actually cause the disease. The risk posed by the vaccine is extremely small, but it is real, and yet poliomyelitis hasn t been seen in the Western Hemisphere since 1991. On an individual basis, a case could be made that the chances of acquiring polio, unless one travels abroad or has contact with people from endemic regions, is even less than that of acquiring vaccine-associated paralytic poliomyelitis. But there is no question that continued polio vaccinations are required in the United States, and indeed a global eradication campaign is underway to completely eliminate the virus. 

Poliomyelitis. Two vaccines are Hcensed for the control of poliomyelitis in the United States. The Hve, attenuated oral polio vims (OPV) vaccine can be used for the immunization of normal children. The killed or inactivated vaccine is recommended for immunization of adults at increased... 

Poliomyelitis is a highly contagious disease that is often asymptomatic however, approximately 1 in every 100 to 1000 cases will develop a rapidly progressive paralytic disease. Polio is caused by poliovirus which has three serotypes type 1 is most frequently associated with paralytic disease. Poliovirus replicates in the oropharynx and intestinal tract and is excreted in oral secretions and feces, which can infect others. As a result, more than 90% of unvaccinated individuals will become infected with poliovirus following household exposure to wild-type poliovirus. Since the introduction of the first poliovirus vaccine, there has been a significant reduction in the number of polio cases. Today, polio caused by wild-type poliovirus has been eradicated from the Western Hemisphere with the goal of eradicating it from the world.11... 

Poling kettle, in tin refining, 24 788 Polioencephalomalacia, 10 867 Poliomyelitis vaccine, 5 345t 25 488 Polio virus, 22 10, 11 Polished metals, and object mode perceptions, 7 306t Pohshes, colloids, 7 273t Pohshing, of staple-fiber non woven fabrics, 27 515... 

Poliomyelitis vaccine (Salk vaccine parenteral) Inactivated poliomyelitis virus Active immunization against polio... 

There are more cases of polio caused by the vaccine in the U.S. than are found overall. However the effectiveness of polio immunization is impressive. In 1986 the number of cases of wild type poliomyelitis which occurred in the Western Hemisphere was 930. In 1989 that number went to 130 in September 1989 it was 11 and there have been no new cases of polio in the U.S. due to the environmental agent since 1979. However,... 

Oral vaccines that are licensed for human administration are limited. Presently, there are few oral vaccines licensed for human use (Table 11.2), although many orally administered vaccine candidates are in development. Live attenuated oral polio (OPV) is the vaccine of choice for the prevention of poliomyelitis... 

Between 1976 and 1985, seven cases of neurological disease were reported to have occurred in Germany among young children after simultaneous administration of oral pohovirus vaccine and diphtheria-tetanus toxoids or diphtheria-tetanus-pertussis vaccine (31). However, the virological data were incomplete only one case was confirmed by the isolation of a vaccine-like polio virus, and in three cases the clinical symptoms did not correspond to poliomyelitis. The author concluded that in some cases the simultaneous administration of injectable vaccines cannot be excluded as a cause for paralysis. 

That infantile paralysis (poliomyelitis), a previously dreaded infectious disease, has been de facto eliminated in Germany and many other countries, is thanks to the vaccine developed by Jonas E. Salk in 1954. In 1961, West Germany had stiU 4.461 recorded cases of polio following the outbreak of an epidemic. However, one year later, after an important campaign under the slogan Oral vaccination is sweet, polio is cruel , only 300 new cases of polio were registered. 

Medicine was still far removed at that time from the levels of care and cure now available. Dr. Dodd was just beginning to treat tuberculosis with streptomycin, one of the miracle drugs that would reverse the ravages of tuberculosis, making it a treatable disease instead of a source of terror and death. Dr. Albert Sabin was at work then at the same hospital developing an oral vaccine for the prevention of poliomyelitis. We residents were treating two buildings full of polio patients in respirators, a stark reminder of how much a vaccine was needed. 

Acute paralytic poliomyelitis is still endemic in some countries and vaccine-associated poliomyelitis continues to occur (125). After many years of stability, some patients do deteriorate (126). This post-polio syndrome may be characterized by the development of progressive weakness associated with respiratory symptoms among those ventilated during their acute illness (127). Respiratory failure results from thoracic restriction as well as muscle weakness and bulbar involvement (128). Tracheostomy can be avoided with continuous NIV and aggressive mechanical in-exsufflation (128). Retrospective studies of NIV have reported survival rates >90% at five years, making this group the one with the highest benefit (76,129). 

---